{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:21:51Z","timestamp":1785230511318,"version":"3.55.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.jsat.2010.05.014","type":"journal-article","created":{"date-parts":[[2010,7,5]],"date-time":"2010-07-05T04:10:52Z","timestamp":1278303052000},"page":"157-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons"],"prefix":"10.1016","volume":"39","author":[{"given":"Michael D.","family":"Stein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra S.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malyna","family":"Kettavong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Cioe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Friedmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir","family":"Tellioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2010.05.014_bib1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1207\/s15327752jpa6703_13","article-title":"Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients","volume":"67","author":"Beck","year":"1996","journal-title":"Journal of Personality Assessment"},{"key":"10.1016\/j.jsat.2010.05.014_bib2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0740-5472(99)00084-7","article-title":"Depression among needle exchange program and methadone maintenance clients","volume":"18","author":"Brienza","year":"2000","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2010.05.014_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archpsyc.1997.01830130077015","article-title":"Psychiatric and substance use comorbidity among treatment-seeking opioid abusers","volume":"54","author":"Brooner","year":"1997","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2010.05.014_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00005053-199204000-00007","article-title":"Reliability of dual diagnosis: Substance dependence and psychiatric disorders","volume":"180","author":"Bryant","year":"1992","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2010.05.014_bib5","first-page":"225","article-title":"Psychiatric illness in male and female narcotic addicts","volume":"43","author":"Croughan","year":"1982","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jsat.2010.05.014_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.psychres.2007.12.007","article-title":"Patterns of major depression and drug-related problems amongst heroin users across 36 months","volume":"166","author":"Darke","year":"2009","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.jsat.2010.05.014_bib7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eurpsy.2004.09.002","article-title":"Depressive symptoms during buprenorphine vs. methadone maintenance: Findings from a randomised, controlled trial in opioid dependence","volume":"19","author":"Dean","year":"2004","journal-title":"European Psychiatry"},{"key":"10.1016\/j.jsat.2010.05.014_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0376-8716(01)00171-5","article-title":"Retention rate and illicit opioid use during methadone maintenance interventions: A meta-analysis","volume":"65","author":"Farre","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2010.05.014_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1300\/J069v22n04_09","article-title":"Guideline development for office-based pharmacotherapies for opioid dependence","volume":"22","author":"Fiellin","year":"2003","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2010.05.014_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJMoa055255","article-title":"Counseling plus buprenorphine\u2013naloxone maintenance therapy for opioid dependence","volume":"355","author":"Fiellin","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2010.05.014_bib11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/ADM.0b013e31809b5df2","article-title":"Two-year experience with buprenorphine\u2013naloxone (suboxone) for maintenance treatment of opioid dependence within a private practice setting","volume":"1","author":"Finch","year":"2007","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2010.05.014_bib12","series-title":"Structured clinical interview for DSM-IV\u2014patient version","author":"First","year":"1995"},{"key":"10.1016\/j.jsat.2010.05.014_bib13","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2010.05.014_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2003.11.017","article-title":"Buprenorphine versus methadone for opioid dependence: Predictor variables for treatment outcome","volume":"75","author":"Gerra","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2010.05.014_bib15","first-page":"3","article-title":"Psychiatric research interview for substance and mental disorders: Phenomenologically based diagnosis in patients who abuse alcohol or drugs","volume":"34","author":"Hasin","year":"1998","journal-title":"Pharmacological Bulletin"},{"key":"10.1016\/j.jsat.2010.05.014_bib16","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2307\/1913827","article-title":"Specification tests in econometrics","volume":"46","author":"Hausman","year":"1978","journal-title":"Econometrica"},{"key":"10.1016\/j.jsat.2010.05.014_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jsat.2006.03.012","article-title":"Depression among heroin users: 12-Month outcomes from the Australian Treatment Outcome Study (ATOS)","volume":"30","author":"Havard","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2010.05.014_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1348\/014466505X68069","article-title":"The Beck Depression Inventory in patients undergoing opiate agonist maintenance treatment","volume":"45","author":"Hess","year":"2006","journal-title":"British Journal of Clinical Psychology"},{"key":"10.1016\/j.jsat.2010.05.014_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1360-0443.1999.9422216.x","article-title":"The quantification of mortality resulting from the regular use of illicit opiates","volume":"94","author":"Hulse","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2010.05.014_bib20","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","volume":"343","author":"Johnson","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2010.05.014_bib21","first-page":"107","article-title":"Validity of the distinction between \u201csubstance-induced\u201d and \u201cindependent\u201d depression and anxiety disorders","volume":"4","author":"Kadden","year":"1995","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.jsat.2010.05.014_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1176\/ajp.156.1.115","article-title":"Past-year use of outpatient services for psychiatric problems in the National Comorbidity Survey","volume":"156","author":"Kessler","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2010.05.014_bib23","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/archpsyc.1985.01790340045007","article-title":"DSM-III psychiatric diagnosis of narcotic addicts: Recent findings","volume":"42","author":"Khantzian","year":"1985","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2010.05.014_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0740-5472(90)90035-O","article-title":"Depressive symptoms during buprenorphine treatment of opioid abusers","volume":"7","author":"Kosten","year":"1990","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2010.05.014_bib25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/00952998809001557","article-title":"Suicidality among opioid addicts: 2.5 year follow-up","volume":"14","author":"Kosten","year":"1988","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2010.05.014_bib26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1360-0443.1996.91685911.x","article-title":"Validity of the SCID in substance abuse patients","volume":"91","author":"Kranzler","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2010.05.014_bib27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0010-440X(95)90073-X","article-title":"Validity of psychiatric diagnoses in patients with substance use disorders: Is the interview more important than the interviewer?","volume":"36","author":"Kranzler","year":"1995","journal-title":"Comprehensive Psychiatry"},{"key":"10.1016\/j.jsat.2010.05.014_bib28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0025-7125(16)30749-0","article-title":"Anxiety and depression in substance abuse: Clinical impications","volume":"72","author":"Kranzler","year":"1988","journal-title":"Medical Clinics of North America"},{"key":"10.1016\/j.jsat.2010.05.014_bib29","first-page":"1581","article-title":"Predictive factors of response to buprenorphine in the substitutive treatment of heroin addicts. Results of a multicenter study of 73 patients","volume":"30","author":"Laqueille","year":"2001","journal-title":"Presse Medicale"},{"key":"10.1016\/j.jsat.2010.05.014_bib30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11606-008-0866-8","article-title":"Home buprenorphine\/naloxone induction in primary care","volume":"24","author":"Lee","year":"2009","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.jsat.2010.05.014_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1300\/J069v26n02_03","article-title":"Outcomes of buprenorphine maintenance in office-based practice","volume":"26","author":"Magura","year":"2007","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2010.05.014_bib32","first-page":"31","article-title":"Effectiveness of buprenorphine in double diagnosed patients: Buprenorphine as a psychotropic drug","volume":"8","author":"Maremmani","year":"2006","journal-title":"Heroin Addiction & Related Clinical Problems"},{"key":"10.1016\/j.jsat.2010.05.014_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0376-8716(00)00162-9","article-title":"The economic costs of heroin addiction in the United States","volume":"61","author":"Mark","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"issue":"Suppl","key":"10.1016\/j.jsat.2010.05.014_bib34","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1111\/j.1360-0443.1996.tb02326.x","article-title":"Taxonomy of high-risk situations for alcohol relapse: Evolution and development of a cognitive\u2013behavioral model","volume":"91","author":"Marlatt","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2010.05.014_bib35","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/archpsyc.1983.04390010030004","article-title":"Predicting response to alcohol and drug abuse treatment: Role of psychiatric severity","volume":"40","author":"McLellen","year":"1983","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2010.05.014_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0165-1781(85)90057-5","article-title":"The Modified Hamilton Rating Scale for Depression: Reliability and validity","volume":"14","author":"Miller","year":"1985","journal-title":"Psychiatry Research"},{"issue":"Suppl","key":"10.1016\/j.jsat.2010.05.014_bib37","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1046\/j.1360-0443.91.12s1.7.x","article-title":"What predicts relapse? Prospective testing of antecedent models","volume":"91","author":"Miller","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2010.05.014_bib38","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1370\/afm.665","article-title":"Treating opioid addiction with buprenorphine\u2013naloxone in community-based primary care settings","volume":"5","author":"Mintzer","year":"2007","journal-title":"Annals of Family Medicine"},{"key":"10.1016\/j.jsat.2010.05.014_bib39","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/biostatistics\/kxh001","article-title":"Analyzing incomplete longitudinal clinical trial data","volume":"5","author":"Molenberghs","year":"2004","journal-title":"Biostatistics"},{"key":"10.1016\/j.jsat.2010.05.014_bib40","first-page":"241","article-title":"A modification of the structured clinical interview for DSM-III-R to evaluate methadone patients test retest reliability","volume":"5","author":"Nunes","year":"1996","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.jsat.2010.05.014_bib41","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1001\/jama.291.15.1887","article-title":"Treatment of depression in patients with alcohol or other drug dependence: A meta-analysis","volume":"291","author":"Nunes","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2010.05.014_bib42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archpsyc.55.2.153","article-title":"Imipramine treatment of opiate dependent patients with depressive disorders: A placebo-controlled trial","volume":"55","author":"Nunes","year":"1998","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2010.05.014_bib43","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.biopsych.2004.06.037","article-title":"Treatment of depression in patients with opiate dependence","volume":"56","author":"Nunes","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jsat.2010.05.014_bib44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7326\/0003-4819-133-1-200007040-00008","article-title":"Pharmacologic treatment of heroin-dependent patients","volume":"133","author":"O'Connor","year":"2000","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2010.05.014_bib45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/jama.287.2.203","article-title":"National trends in the outpatient treatment of depression","volume":"287","author":"Olfson","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2010.05.014_bib46","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1","article-title":"Econometric methods for fractional response variables with an application to 401(k) plan participation rates","volume":"11","author":"Papke","year":"1996","journal-title":"Journal of Applied Econometrics"},{"key":"10.1016\/j.jsat.2010.05.014_bib47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0376-8716(98)00032-5","article-title":"Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts","volume":"50","author":"Petrakis","year":"1998","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2010.05.014_bib48","first-page":"153","article-title":"Trends in prescribing of selective serotonin reuptake inhibitors and other newer antidepressant agents in adult primary care","volume":"5","author":"Pirraglia","year":"2003","journal-title":"Primary Care Companion to the Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jsat.2010.05.014_bib49","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archpsyc.1986.01800080025004","article-title":"Prognostic significance of psychopathology in treated opiate addicts: A 2.5 year follow-up study","volume":"43","author":"Rounsaville","year":"1986","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2010.05.014_bib50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archpsyc.1982.04290020021004","article-title":"Diagnosis and symptoms of depression in opiate addicts: Course and relationship to treatment outcome","volume":"39","author":"Rounsaville","year":"1982","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2010.05.014_bib51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jsat.2004.06.001","article-title":"A conceptual framework for drug treatment process and outcomes","volume":"27","author":"Simpson","year":"2004","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2010.05.014_bib52","series-title":"Measuring Alcohol Consumption","first-page":"41","article-title":"Timeline follow-back: A technique for assessing self-reported alcohol consumption","author":"Sobell","year":"1992"},{"key":"10.1016\/j.jsat.2010.05.014_bib53","series-title":"Stata Statistical Software: Release 10","author":"StatCorp","year":"2007"},{"key":"10.1016\/j.jsat.2010.05.014_bib54","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1037\/h0080631","article-title":"Use of the revised Beck Depression Inventory with intravenous drug users not in treatment","volume":"6","author":"Steer","year":"1992","journal-title":"Psychology of Addictive Behaviors"},{"key":"10.1016\/j.jsat.2010.05.014_bib55","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0193-953X(05)70081-2","article-title":"Medical consequences of substance abuse","volume":"22","author":"Stein","year":"1999","journal-title":"The Psychiatric Clinics of North America"},{"key":"10.1016\/j.jsat.2010.05.014_bib56","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1525-1497.2005.0228.x","article-title":"Buprenorphine retention in primary care","volume":"20","author":"Stein","year":"2005","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.jsat.2010.05.014_bib57","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00005053-199104000-00007","article-title":"Early treatment time course of depressive symptoms in opiate addicts","volume":"179","author":"Strain","year":"1991","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2010.05.014_bib58","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/10550490490459924","article-title":"Depressive symptoms in adolescents during residential treatment for substance use disorders","volume":"13","author":"Subramaniam","year":"2004","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.jsat.2010.05.014_bib59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/10550880802122646","article-title":"Psychotherapeutic benefits of opioid agonist therapy","volume":"27","author":"Tenore","year":"2008","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2010.05.014_bib60","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.drugalcdep.2005.11.020","article-title":"Predictors of retention in methadone programs: A signal detection analysis","volume":"83","author":"Villafranca","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2010.05.014_bib61","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/jama.283.2.212","article-title":"Impact of disseminating quality improvement programs for depression in managed primary care: A randomized controlled trial","volume":"283","author":"Wells","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2010.05.014_bib62","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/archpsyc.1983.04390010049006","article-title":"Psychotherapy for opiate addicts: Does it help?","volume":"40","author":"Woody","year":"1983","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2010.05.014_bib63","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1046\/j.1360-0443.2003.00354.x","article-title":"Does retention matter? Treatment duration and improvement in drug use","volume":"98","author":"Zhang","year":"2003","journal-title":"Addiction"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547210001182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547210001182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:33:49Z","timestamp":1760038429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547210001182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0740547210001182"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2010.05.014","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2010.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}